DOK7 and amyotrophic lateral sclerosis: This study establishes proof of concept that DOK7 gene therapy, or potentially other methods that are able to enlarge NMJs after ALS onset, may be a novel treatment approach, either as a self‐contained therapy or in combination with other therapies such as those aimed at promoting motor neuron survival.